Production (Stage)
Medpace Holdings, Inc.
MEDP
$447.49
-$8.19-1.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 603.31M | 558.57M | 536.59M | 533.32M | 528.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 603.31M | 558.57M | 536.59M | 533.32M | 528.10M |
| Cost of Revenue | 185.83M | 177.82M | 167.52M | 171.54M | 171.54M |
| Gross Profit | 417.49M | 380.75M | 369.07M | 361.78M | 356.56M |
| SG&A Expenses | 46.66M | 57.90M | 45.43M | 49.22M | 41.45M |
| Depreciation & Amortization | 7.01M | 6.93M | 7.51M | 7.52M | 7.24M |
| Other Operating Expenses | 237.47M | 202.40M | 190.75M | 192.77M | 202.73M |
| Total Operating Expenses | 476.98M | 445.05M | 411.21M | 421.04M | 422.95M |
| Operating Income | 126.34M | 113.52M | 125.38M | 112.27M | 105.15M |
| Income Before Tax | 124.54M | 118.17M | 133.88M | 118.78M | 110.48M |
| Income Tax Expenses | 34.28M | 3.58M | 16.86M | 22.35M | 22.13M |
| Earnings from Continuing Operations | 90.26M | 114.60M | 117.02M | 96.43M | 88.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.26M | 114.60M | 117.02M | 96.43M | 88.35M |
| EBIT | 126.34M | 113.52M | 125.38M | 112.27M | 105.15M |
| EBITDA | 133.35M | 120.45M | 132.88M | 119.79M | 112.39M |
| EPS Basic | 3.16 | 3.77 | 3.78 | 3.11 | 2.85 |
| Normalized Basic EPS | 2.72 | 2.43 | 2.70 | 2.39 | 2.23 |
| EPS Diluted | 3.10 | 3.67 | 3.67 | 3.01 | 2.75 |
| Normalized Diluted EPS | 2.67 | 2.37 | 2.63 | 2.31 | 2.15 |
| Average Basic Shares Outstanding | 28.60M | 30.39M | 30.95M | 31.05M | 30.99M |
| Average Diluted Shares Outstanding | 29.14M | 31.20M | 31.87M | 32.09M | 32.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |